Immunostimulatory effect of dried bonito extract on mouse macrophage cell lines and mouse primary peritoneal macrophages
- 342 Downloads
Dried bonito is a preserved food used in Japan, which contains abundant flavor ingredients and functional substances. We focused on the immunostimulatory effect of dried bonito extract (DBE) on mouse macrophage-like J774.1 cells, RAW264.7 cells, and mouse primary peritoneal macrophages. DBE significantly stimulated the production of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) by both J774.1 cells and peritoneal macrophages by enhancing the cytokine gene expression levels. In addition, DBE stimulated nitric oxide production by enhancing the expression of inducible nitric oxide synthase in RAW264.7 cells. DBE also increased the phagocytosis activity of J774.1 cells. Immunoblot analysis revealed that DBE has an immunostimulatory effect on macrophages through activation of mitogen-activated protein kinase and nuclear factor-κB cascades. TNF-α production enhanced by DBE was partially inhibited by treatment with TLR4 inhibitor TAK-242, whereas IL-6 production enhanced by DBE was almost inhibited. These results suggested that DBE is thought to strongly stimulate the TLR4 signaling pathway for macrophage activation, and its activation is also involved in other signaling. Finally, the phagocytosis activity of peritoneal macrophages from DBE-administered BALB/c mice increased significantly, suggesting that DBE has the potential to stimulate macrophage activity in vivo. In conclusion, these data indicated that DBE contributes to activating host defense against pathogens by activating innate immunity.
KeywordsImmunostimulatory effect Dried bonito J774.1 cells Peritoneal macrophages Phagocytosis activity
We thank members of the Advanced Research Support Center (ADRES), Ehime University for the use of animal facility.
MI, KN, KS, NK, and TS conceived and designed the experiments. MI and KS, and NK performed the experiments and analyzed the data. MI, KN, and TS wrote the manuscript.
Compliance with ethical standards
Conflict of interest
Katsuhiro Osajima, Tomokazu Suemitsu, and Takuya Sugahara are inventors in a patent application filed by Ehime University, which disclose bioactive agents targeting immunostimulation described in the present article. The remaining authors declare no conflict of interest.
- Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141:2407–2412Google Scholar
- Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y (2006) A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol 69:1288–1295CrossRefGoogle Scholar
- Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142Google Scholar
- Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051–3064Google Scholar
- Sanghera JS, Weinstein SL, Aluwalia M, Girn J, Pelech SL (1996) Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J Immunol 156:4457–4465Google Scholar
- Xie Q, Kashiwabara Y, Nathan C (1994) Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705–4708Google Scholar
- Zhang Y, Dong C (2005) MAP kinases in immune responses. Cell Mol Immunol 2:20–27Google Scholar